The agent successfully assembled a comprehensive overview of Portrai's business, technology, and market position by combining direct site fetches with web search and prior knowledge. The site itself provides clear product descriptions and company information, but critical details like pricing and competitive differentiation are either absent or scattered; the agent had to fill substantial gaps through external research and inference.

• ›Steps [2] (homepage), [8] (services/platform page), and [13] (spatial database page) directly returned product descriptions, service names (PortraiDISCOVERY, PortraiTARGET, PortraiMIX, PortraiTME), and database scale (2,000+ samples, 50M+ cells). These pages were the primary source for 'what Portrai does' and 'who it's for.'
• ›Step [14] (CBInsights company profile) was explicitly cited and provided founding year (2021), funding ($14.5M), and spatial transcriptomics focus — information not prominently available on the official site itself.
• ›Pricing was completely unavailable on the site; the agent correctly identified this gap and explained the business model (custom co-development pricing typical of B2B biotech) based on inferences from product positioning rather than published information.
• ›The official site lacks explicit competitive positioning or comparison to 10x Genomics and NanoString; the agent synthesized competitor analysis from external search results ([16]) rather than site content, filling a major content gap.
• ›Service vs. co-development distinction remains ambiguous despite the agent's efforts—the site mentions 'co-development' but does not clearly articulate when each model applies or what the customer journey differs between them.
• ›The site is moderately agent-ready for product discovery (clear service names, therapeutic focus) but weak on business model transparency (no pricing), competitive context (no explicit differentiation messaging), and customer proof points (no case studies or success stories indexed).